Sleeping Bruxism Treatment Market Growth Rate Research Report, Historical Analysis

Sleeping bruxism (SB) is a condition in which people tend to grind or clench their teeth during sleep. Chronic teeth grinding disorder can result in fracturing the jaw, loss of teeth, including tooth loss while boosting various oral health complications. Often more prevalent in children than adults, SB is triggered by multiple causes such as GERD, malocclusion, sleep paralysis, and obstructive sleep apnea.

According to Market Research Future (MRFR), the global sleeping bruxism treatment market is projected to grow to USD 638.2 MN by 2023, registering over 6% CAGR throughout the forecast period (2018 – 2023). Increasing prevalence of sleeping bruxism and changing lifestyles are some of the key driving forces supporting market growth.

Besides, the availability of therapeutic medicines in the form of muscle relaxants, and antidepressants are fuelling the market growth, providing growth opportunities to the market. Additional factors that substantiate the market growth include increasing population and the growing awareness of the availability of treatments for the disorder.

Simultaneously, the improving economy provides impetus to market growth, enabling full access to quality life & improved healthcare worldwide. Technological advances led by substantial R&D investments foster market growth, excellently. Also, the innovation & development of medical devices, treatments & medicines boosts the market's growth.

Global Sleeping Bruxism Treatment Market – Segments

The report is segmented into seven dynamics;

By Types: Primary and Secondary Bruxism, among others.

By Diagnosis: Clinical Examination, Electromyographic Methods, Polysomnography, and X-rays among others.

By Treatment Types: Dental Approaches (Mouth Guard and NTI-TSS Device) and Medication (Muscle Relaxants, Botox Injections, Anti-anxiety Drugs, others), and others.

By Causes: Malocclusion, Sleep Paralysis, Obstructive Sleep Apnea, Gastroesophageal Reflux Disease (GERD), and others.

By Patient Types: Pediatric and Adult (Male and Female).

By End-Users: Hospitals & Clinics, Dental Clinics, and others.

By Regions:  Europe, Americas, APAC, and Rest-of-the-World.

Major Players:

Players leading the sleeping bruxism treatment market include Ipsen Biopharmaceuticals, Inc., Ivoclar Vivadent AG, Merz Pharma GmbH & Co. KGaA, Akervall Technologies Inc., Carestream Dental, PLANMECA OY, S4S Dental Laboratory, Randmark Dental Products, LLC, Patterson Dental Supply, Inc., Pfizer Inc., and Henry Schein, Inc., among others. 

Article source: https://article-realm.com/article/Sports-Recreation/12593-Sleeping-Bruxism-Treatment-Market-Growth-Rate-Research-Report-Historical-Analysis.html